Furthermore, the results of this study also provided preliminary evidence that extracellular galectin-3 binds to the insulin receptor directly and attenuates downstream pathways, suggesting galectin-3 to be a novel targetable link between the insulin resistance and T2DM. The gene discussed is INSR; the disease is type 2 diabetes mellitus.